It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel Disease
J Crohns Colitis
.
2018 Mar 28;12(4):509.
doi: 10.1093/ecco-jcc/jjx174.
Authors
Lieven Pouillon
1
2
,
Laurent Peyrin-Biroulet
1
Affiliations
1
Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Nancy 1, Allée du Morvan, Vandœuvre-lès-Nancy, France.
2
Imelda GI Clinical Research Centre, Imeldaziekenhuis Bonheiden, Imeldalaan, Bonheiden, Belgium.
PMID:
29309565
DOI:
10.1093/ecco-jcc/jjx174
No abstract available
Publication types
Letter
MeSH terms
Feces / chemistry
Humans
Inflammatory Bowel Diseases / therapy*
Leukocyte L1 Antigen Complex / analysis
Patient Care Planning
Practice Guidelines as Topic*
Substances
Leukocyte L1 Antigen Complex